Connect with us

antidepressants

Treating Depression: Psychedelics vs. Antidepressants

Published

on


Recent research suggests that psychedelics and traditional antidepressants, while both potentially effective in treating depression, work through distinct mechanisms. Understanding these differences could lead to more personalized and effective treatment approaches. Psychedelics vs. Antidepressants: What are the key differences?

Unlocking the Mysteries of Depression Treatment: Psychedelics vs. Antidepressants

The quest for effective depression treatments continues to be a significant focus in mental health research. Traditional antidepressants, like selective serotonin reuptake inhibitors (SSRIs), have been a mainstay in treatment, prescribed widely despite varying efficacy among individuals and often accompanying unwanted side effects. In contrast, psychedelics have recently garnered attention for their rapid and enduring antidepressant effects observed in clinical trials.

A recent study has delved into the distinct mechanisms of action of SSRIs and psychedelics, illuminating how they uniquely influence the brain and potentially alleviate symptoms of depression. SSRIs primarily increase serotonin levels in the brain, which is believed to enhance mood and diminish depressive symptoms. However, this process can require several weeks to manifest noticeable effects, and not all patients respond favorably to SSRIs.

Conversely, psychedelics such as psilocybin, found in “magic mushrooms,” operate through a different mechanism. Research indicates that psilocybin’s antidepressant effects are not directly due to elevated serotonin levels. Instead, psilocybin is thought to promote neuroplasticity, the brain’s capacity to reorganize and form new neuronal connections. This heightened neuroplasticity may facilitate more adaptable thought patterns and an improved ability to process emotions, contributing to the rapid and sustained antidepressant effects seen in clinical trials.

Moreover, the study examined the role of the 5-HT2A serotonin receptor, a primary target for both SSRIs and psychedelics. While SSRIs inhibit this receptor’s activity, psychedelics activate it. Intriguingly, blocking the 5-HT2A receptor did not reduce psilocybin’s antidepressant effects, suggesting that its therapeutic benefits originate from other pathways.

Psychedelics vs. Antidepressants: Why It Matters?

Understanding the distinct mechanisms by which psychedelics and antidepressants affect the brain is crucial for the development of more personalized and effective treatment strategies for depression. This knowledge could lead to enhanced patient selection for specific treatments, reducing trial and error while optimizing outcomes. Furthermore, exploring the unique properties of psychedelics may pave the way for novel antidepressant medications that are quicker acting and have fewer side effects.

Potential Implications

This research could catalyze a shift in depression treatment paradigms, moving from a one-size-fits-all approach to more targeted therapies. By pinpointing the specific mechanisms that underlie different antidepressant interventions, clinicians can customize treatment plans based on individual patient profiles and needs. This personalized approach could improve treatment success rates and enhance the quality of life for individuals battling depression.

What Next?

While the study of psychedelics for therapeutic purposes is still in its nascent stages, the initial findings are promising and suggest that psychedelics may offer a valuable addition to the arsenal of tools for combating depression and other mental health conditions.

Source: Neuroscience News



Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

antidepressants

Antidepressants Numb Emotions Says New Study — Time To Switch To Cannabis?

Published

on

By


Emotional blunting, also referred to as numbness, is common among people who medicate with antidepressants. When this occurs, one can neither feel happy nor sad. You simply feel numb, unable to cry or laugh when the situation calls for it and you may even feel less empathy for others. It can also significantly decrease your motivation as well as your enjoyment when you do things that used to bring you joy. That is the double-edged sword that comes with taking antidepressants, on top of all the side effects that each medicine can already bring about.

A new study analyzed the effects of Lexapro, a selective serotonin reuptake inhibitor. Lexapro is a common antidepressant, acting on the serotonin levels which we know as reuptake sites. It inhibits serotonin recycling in these parts of the brain which allows us to retain more serotonin so that symptoms of depression are reduced. For most people, it takes medicating with Lexapro and other SSRI’s for around four weeks for its full effects to be felt. But is it worth the emotional numbing that comes with it?

The report finds that around 40-60% of the population who consume SSRI’s experience emotional blunting. It also finds that things are no longer as pleasurable, though it’s not clear if this is an effect of depression or the drug.

depression anxiety
Photo by Maskot/Getty Images

One of the latest studies on the topic, published in the journal Neuropsychopharmacology, was conducted by researchers at the University of Cambridge, led by Prof. Barbara Sahakian. She discloses to The Guardian: “In a way, this may be in part how they work. They take away some of the emotional pain that people who experience depression feel, but unfortunately it seems that they also take away some of the enjoyment,” she says about emotional blunting.

For the study, 66 volunteers were tasked to take either escitalopram (generic name of Lexapro), or a placebo, for a period of 21 days. After that, they were asked to do a series of cognitive tests which measured their memory and attention as well as other functions. According to Sahakian, escitalopram didn’t make a difference in the test results. “The drug isn’t doing anything negative to cognition – from that point of view it’s very good,” she says.

On the other hand, the study participants who were taking SSRIs were also found to be less responsive when exposed to reinforcement learning, since they were asked to respond to positive or negative stimulus. They were shown two screens, one of which would give a reward 4 out of 5 times while the other screen would only give a reward once in 5 times. They eventually learned to choose the positive reinforcement screen but the probabilities were changed up so the participants didn’t know what to expect with the new rulings.

RELATED: Study: Cannabis Can Help Alleviate Insomnia In Those Suffering From Depression & Anxiety

In addition, the volunteers who took SSRIs reported that they experienced more difficulties reaching orgasm during intercourse. This is a well-known side effect of SSRIs.

According to experts, the emotional blunting that SSRI medications causes is also related to dose, as well as its effects on the prefrontal cortex and frontal lobes. Patients have the option of lowering SSRI doses or changing their medications as needed.

cannabis prescription drugs
Photo by SageElyse/Getty Images

Is Cannabis a Better Substitute for Depression?

Cannabis has two primary cannabinoids: psychoactive THC (tetrahydrocannabinol) and relaxing CBD (cannabidiol). The human body has endocannabinoid receptors found all throughout, especially in the brain, which these cannabinoids bind to and help treat a multitude of mental health disorders.

Countless people have had success medicating with marijuana for depression as well as anxiety.

In a 2022 study of more than 7,000 adults with diagnosed with depression and anxiety, researchers found that marijuana use was associated with improvements in symptoms of depression and anxiety. Even better, the effects of cannabis were long term: the improvements were observed 12 and 18 months after treatment.

RELATED: Cannabis Provides Immediate Relief For Symptoms Of Depression, Other Mental Health Issues

“To our knowledge, this study is the largest completed to date examining the impact of medical cannabis use on anxiety and depression outcomes utilizing longitudinal data and validated questionnaires,” they wrote. “It provides evidence on the effectiveness of medical cannabis as treatment for anxiety and depression that otherwise is not currently available, demonstrating that patients who seek treatment with medical cannabis for anxiety and depression can experience clinically significant improvements,” they wrote.

“This study offers reasonable justification for the completion of large clinical trials to further the understanding of medical cannabis as a treatment for anxiety and depression,” concluded the authors.

Meanwhile, another study found that long-term consumption of CBD cannabis also helps patients struggling with depression, anxiety, and pain. Canadian researchers analyzed the impact of CBD products on 279 subjects over the course of six months. Patients who had severe symptoms appeared to benefit the most.

cannabis CBD oil
Photo by Tinnakorn Jorruang/Getty Images

“This study on CBD-rich products demonstrates the potential of RWE (real-world evidence) for the advancement of medical cannabis research and practice guidelines, especially in a world where CBD use is exponentially increasing but scientific data are limited,” they wrote.

“It revealed that CBD-rich treatments have a beneficial impact on patients with self-reported moderate or severe symptoms of pain, anxiety, or depression and overall wellbeing but not in patients with mild symptoms,” write the authors.

Conclusion

There is definitely promising evidence that marijuana can help with depression. It may require some trial and error with various THC and CBD products until you find exactly what works for you. Nonetheless, it’s a much safer alternative that won’t numb your emotions yet it works so well for many people. There are no side effects to worry about, but if you are already taking existing medications, do talk to your healthcare provider about integrating cannabis into your wellness routine.

This article originally appeared on Cannabis.net and has been reposted with permission.



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media